Product-Market Fit in Uncharted Territory: How Aclid Found Their First 10 Customers

Discover how Aclid achieved product-market fit in biosecurity through intensive customer discovery, strategic pivots, and targeting early-stage manufacturers. Essential lessons for founders entering regulated markets.

Written By: supervisor

0

Product-Market Fit in Uncharted Territory: How Aclid Found Their First 10 Customers

Product-Market Fit in Uncharted Territory: How Aclid Found Their First 10 Customers

Finding product-market fit is challenging in any industry. But in synthetic biology, where a single misstep could have catastrophic consequences, the stakes are exponentially higher. In a recent episode of Category Visionaries, Aclid founder Kevin Flyangolts revealed their methodical approach to finding their first customers in this high-stakes market.

The Initial Discovery Phase

Instead of building first and validating later, Aclid took a research-heavy approach. “We spent probably the first three months talking to 40 to 60 different manufacturers and just learning, figuring out what it is that they do day to day,” Kevin explains. “Where are the biggest pain points? Is it in the screening? Is it in the vetting of the customer? Is it somewhere totally else?”

This wasn’t casual market research. Each conversation aimed to uncover specific operational challenges in DNA manufacturing security. The process revealed that manufacturers were struggling with manual compliance processes that were both inefficient and potentially risky.

Finding the Right Co-founder

A crucial early decision was partnering with someone who brought complementary expertise. Kevin connected with Professor Harris Wong at Columbia University, and “we got connected immediately hit it off and realized we have a lot of the same ambitions, super complementary skill sets. He obviously has a lot deeper of bio background than I do, and I come from an operational background.”

This partnership proved essential for credibility and access. “Harris is pretty established researcher,” Kevin notes. “He has a big name in the industry… So definitely a lot of intros, warm connections from him helped build some of that trust.”

Identifying the Initial Target Market

A counterintuitive insight emerged from their research. While large manufacturers had built internal systems, early-stage companies were drowning in compliance requirements. “When you’re an early stage company, you are dealing with a lot of problems,” Kevin explains. “If you’re starting a company that requires facilities, 50 people, just to get started, just to build your first product and sell it to a customer, there’s just that much more. And dealing with compliance burdens along that way makes it that much harder.”

This realization led them to focus on early-stage manufacturers who lacked resources for comprehensive in-house solutions.

The Pandemic Catalyst

Market timing proved crucial. “This was at the height of the pandemic,” Kevin notes. “Obviously, security was top of mind. There was a whole ton of attention being put on this space of synthetic biology and what it means to do it safely.”

This heightened awareness of biosecurity created an opportunity to position their solution not just as a compliance tool, but as essential infrastructure for responsible innovation.

Building the Right Solution

The depth of their customer discovery revealed specific operational bottlenecks. They found manufacturers were “calling up a customer, avoid having to screen their order and look at what’s inside.” Aclid’s solution automated these processes end-to-end, helping manufacturers verify “that they have the right permissions, the right facilities and the right documents to actually ship the order and do it without any type of liability or risk of non compliance.”

Evolution to Enterprise

As they proved their value with early-stage manufacturers, larger players took notice. “Now we’re starting to work with some of the largest manufacturers in the space,” Kevin shares, “replacing their in house systems, making them more automated, and giving them their ability to focus back on the chemistry and the manufacturing, rather than on the administrative burden of compliance.”

Key Lessons for Finding Product-Market Fit in Regulated Markets

  1. Invest heavily in customer discovery before building
  2. Partner with domain experts who bring credibility
  3. Look for acute pain points in underserved segments
  4. Time market entry with broader industry trends
  5. Focus on automation that removes administrative burden

For founders entering regulated markets, Aclid’s journey offers a valuable blueprint. Start with deep customer discovery, find credible partners, and focus on segments where the pain is so acute that customers are willing to try new solutions. Most importantly, think beyond immediate compliance needs to envision how the entire industry could operate more efficiently.

Leave a Reply

Your email address will not be published. Required fields are marked *

Write a comment...